Our Bethlehem site, renowned since 1991 as a leading contract development and manufacturing organization, is now seamlessly integrated into Agno Pharma. Following its acquisition on December 15, 2023, Particle Sciences continues its legacy of excellence under our umbrella. Our team of experienced industry experts specializes in complex drug product formulation development and manufacturing, drug implant development, and a comprehensive suite of supporting services.

From analytical and physical characterization to cGMP clinical supply manufacturing, we offer a diverse range of formulation development technologies. Our expertise in solutions for poorly soluble and highly potent compounds, in both sterile and non-sterile environments, sets us apart from other CDMO service providers. At Agno Pharma, we are dedicated to exceeding the needs of our clients at every stage of their journey.

Today, our Clientele include over half of the leading pharmaceutical and biotech companies, foundations, universities, and privately-backed start-ups.